Ike: I think one of the things i, uhopeful happens in the contects of coved is far more robust bio security. And cov it represents a moment where it's like, wel, it's a good idea to build this right now because it helps open economies. It helps avoid a wave in the fall. Like, why not give a perfect moment to build out really robust, pile security tools that then will serve us very well as we enter the next fifty years? Ike: We want to make it cheaper and easier until your kids are programming cells some day. Yes? Yes.
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!